A carregar...
Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy
Fludarabine-based regimens and CHOP (doxorubicin, cyclophosphamide, vincristine, prednisone)-like regimens with or without rituximab are the most common treatment modalities for indolent lymphoma. However, there is no clear evidence to date about which chemotherapy regimen should be the proper initi...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3797259/ https://ncbi.nlm.nih.gov/pubmed/24143112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S47764 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|